Status
Conditions
About
The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options for malignant tumors are poor. The current study investigates different aspects of the pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with adrenocortical carcinoma.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:
Exclusion Criteria:
500 participants in 2 patient groups
Loading...
Central trial contact
Martin Fassnacht, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal